Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aoxing Pharma revenue falls in FY2010
The reduction of revenue occurred because Aoxing consolidated its manufacturing facilities in the summer of 2009, requiring re-certification or the facilities by the Chinese government. Loss from operations
The reduction of revenue occurred because Aoxing consolidated its manufacturing facilities in the summer of 2009, requiring re-certification or the facilities by the Chinese government. Loss from operations
Karsunky most recently served as CFO in the Consumer Health Division of Novartis, where he took up the responsibilities of the division’s finance, information technologies, procurement and merger
The initial expansion will create 205 new jobs, including 85 in the Clayton facility, which currently produces a number of products, including the Levemir FlexPen (insulin detemir [rDNA
Dynavax’s Heplisav is a TLR9 agonist and Engerix-B is a commercially available hepatitis B vaccine. Dynavax’s Phase 3 Heplisav Short-regimen Trial (PHAST), a previously reported Phase 3 multicenter
Following FDA’s complete response letter, HGS and Novartis have jointly decided to terminate the development of Zalbin. Zalbin is a genetic fusion of human albumin and interferon alfa
Tapentadol is a centrally-acting analgesic with a dual mode of action as an agonist at the µ-opioid receptor and as a norepinephrine reuptake inhibitor. J&JPRD’s NDA was filed
The patents cover the various properties of Protectan CBLB612 and related compounds, including composition of matter and methods of use for protecting against apoptosis. Protectan CBLB612 is a
The new kits are a combination of Gentel’s APiX chromogenic detection technology and RayBiotech, collection of more than 55 antibody and protein arrays on a glass-slide format and
The brand products had combined annual sales of $1.6bn in the US, based on IMS sales data for the 12 months ended June 2010. Mumbai, India-based Lupin Limited
According to the report filed with the Bombay Stock Exchange, the Mumbai-based company will increase its board presence to five seats from the previous two in the seven-member